Dr. Zhiyuan Wu 吴志远
Chief Physician
Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional minimally invasive treatment for thoracic and abdominal tumors and vascular diseases, including liver, lung, and endocrine tumors, as well as portal hypertension complications.
Dr. Wu is a Chief Physician and doctoral supervisor at Ruijin Hospital. With over 20 years of experience, Dr. Wu trained at the University of Southern California, Cleveland Clinic, and University of Pittsburgh. Research focuses on interventional therapy for tumors and vascular diseases. Dr. Wu has performed over 2,000 procedures annually and published more than 40 papers.
Professional roles
- Deputy Leader, Portal Hypertension Intervention Expert Working Group, Interventional Physician Branch, Chinese Medical Doctor Association
- Standing Committee Member, Tumor Intervention Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Asian Cryotherapy Society
- Vice Chair, Solid Tumor Focused Diagnosis and Treatment Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Wu Zhiyuan). Papers usually list the name as Zhiyuan Wu or Wu Z.
Selected publications
62 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Med Sci, 2026 (senior author): Longitudinal Radiological Remodeling after Irreversible Electroporation Versus Radiofrequency Ablation: A Prospective Comparative Study (The LIRA Study). PubMed 41938518
- Anticancer Res, 2026 (senior author): Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications. PubMed 41760269
- Biomater Sci, 2023 (senior author): Tungsten-based nanoparticles as contrast agents for liver tumor detection using dual-energy computed tomography. PubMed 37873585
- Endoscopy, 2023 (senior author): Endoscopic ultrasound-guided super-selective partial splenic embolization: New embolic material and multiple safety precautions. PubMed 37611634
- Front Oncol, 2022 (senior author): Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT. PubMed 36059634
- BMC Gastroenterol, 2022 (senior author): The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension. PubMed 35337294
- BMC Cancer, 2021 (senior author): Immunological effect of irreversible electroporation on hepatocellular carcinoma. PubMed 33882892
- J Interv Med, 2020 (first author): Irreversible electroporation treatment of pheochromocytoma at a complex site: A case report. PubMed 34805917
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion